short dystrophin

AVI BioPharma has begun phase 2 testing of its experimental exon-skipping drug eteplirsen (AVI-4658) in boys with Duchenne MD

posted on August 15, 2011 - 11:37am
Updated: View MDA's video about the launch of the eteplirsen trial on YouTube.

New content is being added every day. Please check back again.